Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5772629A · kind A · utility
55Cited by
15References
27Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 23, 1995 |
| Grant date | Jun 30, 1998 |
| Priority date | — |
| Expiry date | Oct 23, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2025/1072
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Restenosis in recanalized blood vessels is inhibited by delivering tissue factor pathway inhibitor (TFPI) intramurally at a target site within the blood vessel. Usually, TFPI is delivered using a catheter having infusion ports at its distal end. Optionally at the distal end of the catheter is radially expanded to engage the infusion ports directly against the blood vessel wall.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.